Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
388
datasets available to search
ShareScore release 0.7.1
Dataset results
388 results for “alcoholic fatty liver disease”
Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT01720719. IPD Sharing: Not stated. Countries: 1. Publications: 37.
Effect of PNPLA3, TM6SF2 and MBOAT7 Genetic Variants on Non-alcoholic Fatty Liver Disease Therapeutic Outcome.
ClinicalTrials.gov study NCT04640324. IPD Sharing: YES. Countries: 1. Publications: 23.
A Digital Solution for Individuals With Non Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT05426382. IPD Sharing: NO. Countries: 1. Publications: 1.
The Effect of Probiotics on Non Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT00808990. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Can Fecal Calprotectin Be Used as a Biomarker of Non-alcoholic Fatty Liver Disease In Obese Adolescents?
ClinicalTrials.gov study NCT06229184. IPD Sharing: NO. Countries: 1. Publications: 1.
Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study
ClinicalTrials.gov study NCT02754037. IPD Sharing: NO. Countries: 1. Publications: 1.
Effectiveness of Nutrition Education Program and Omega-3 Supplementation Among Non-alcoholic Fatty Liver Disease Patients
ClinicalTrials.gov study NCT06627114. IPD Sharing: NO. Countries: 1. Publications: 4.
Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT00641524. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effectiveness of Inactive Vitamin D Supplementation in Non-Alcoholic Fatty Liver Disease Patients
ClinicalTrials.gov study NCT05613192. IPD Sharing: NO. Countries: 1. Publications: 1.
Pharmacoeconomic Evaluation of the Cost/effectiveness Ratio of Physical Exercise on Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT06026293. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD)
ClinicalTrials.gov study NCT04237116. IPD Sharing: YES. Countries: 2. Publications: 0.
The Effect of Consecutive Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease (NAFLD)
ClinicalTrials.gov study NCT04465032. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)
ClinicalTrials.gov study NCT04951219. IPD Sharing: Not stated. Countries: 2. Publications: 1.
S.P.PRO LIVER POWDER is Used to Improve Liver and Metabolic Indexes in People With Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT04718051. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Effects of Bariatric Surgeries on Non-Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT01619215. IPD Sharing: Not stated. Countries: 1. Publications: 19.
Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT00633282. IPD Sharing: Not stated. Countries: 1. Publications: 11.
Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT02690792. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT03060538. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Non Alcoholic Fatty Liver Disease: Nutritional Epidemiology and Lifestyle Medicine
ClinicalTrials.gov study NCT03300661. IPD Sharing: NO. Countries: 1. Publications: 1.
The Influence of SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver Disease Evolution
ClinicalTrials.gov study NCT05416970. IPD Sharing: YES. Countries: 1. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.